FDA Inspection 1178471 — Nautilus Protein Inc
The FDA completed an inspection of Nautilus Protein Inc on Sep 8, 2022 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 8, 2022
- Fiscal Year
- 2022
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- San Diego, CA (United States)
Additional Details
FSVP